Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Arizona ave
Santa Monica, CA 90404
Summary
- Dr. Vivian Wu is an Otolaryngologist in Los Angeles. She specializes in Head & Neck Oncologic Surgery. Her training includes a fellowship in Head & Neck Surgical Oncology at the University of Michigan Health System and a residency in Otolaryngology - Head and Neck Surgery at Oregon Health & Science University. She has also authored several well-cited publications in the fields of surgical pathology and oncology.
Education & Training
- University of Michigan Health SystemFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2011 - 2013
- Oregon Health & Science University (OHSU Health)Residency, Otolaryngology - Head and Neck Surgery, 2004 - 2011
- Howard University College of MedicineClass of 2004
Certifications & Licensure
- OR State Medical License 2010 - Present
- MI State Medical License 2011 - 2027
- CA State Medical License 2024 - 2026
- VA State Medical License 2013 - 2018
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Publications & Presentations
PubMed
- 33 citationsDisparities in the Uptake of Telemedicine During the COVID-19 Surge in a Multidisciplinary Head and Neck Cancer Population by Patient Demographic Characteristics and S...Samantha Tam, Vivian F. Wu, Amy M. Williams, Marian Girgis, Jawad Sheqwara
JAMA Otolaryngology-- Head & Neck Surgery. 2021-02-01 - 4 citationsSentinel Node Biopsy for Head and Neck Cutaneous Melanoma.Vivian F. Wu, Kelly M. Malloy
Otolaryngologic Clinics of North America. 2021-04-01 - 10 citationsAltering MYC phosphorylation in the epidermis increases the stem cell population and contributes to the development, progression, and metastasis of squamous cell carci...Xiaoyan Wang, Ellen M. Langer, Colin J. Daniel, Mahnaz Janghorban, Vivian F. Wu
Oncogenesis. 2020-09-07
Press Mentions
- Nektar Therapeutics Presents New Data from Its Immuno-Oncology Pipeline at the 2020 Society for Immunotherapy of Cancer (SITC) Annual MeetingNovember 11th, 2020
- Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin plus Nivolumab in 'Cancer Discovery' JournalMay 22nd, 2020
- Hospitals Don’t Shift Costs from Medicare or Medicaid to Private InsurersJune 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: